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1. Introduction 
Cholinergic receptors in vertebrates are usually 
classified into two main types, nicotinic and musca- 
rinic [l] . It has been suggested that cholinergic 
receptors in insects do not fall into one of these 
categories but are of a mixed nicotinic and musca- 
rinic nature [2-S]. However, it was recently found 
that flies do contain a nicotinic receptor similar to 
that of vertebrates ([6-91 , Rudloff, submitted). We 
report here that the fruit fly, Drosophila melano- 
gaster, contains also a distinct muscarinic receptor, 
as revealed by specific binding of the powerful 
muscarinic antagonist [3H]quinuclidinyl benzilate 
([3H]QNB) [lo] . It appears that in contrast with 
vertebrate brain, fly head is richer in nicotinic 
receptors than in muscarinic receptors. 
2. Materials and methods 
Drosophila melanogaster, Canton-Special strain, were 
cultured under standard conditions [l l] . Experiments 
were performed on isolated heads. They were sepa- 
rated from bodies by freezing and shaking and homo- 
genized (400-500 heads/ml) in 0.32 M sucrose, in a 
glass-glass dual homogenizer followed by a glass- 
Teflon homogenizer. The supernatant of 500 X g 
centrifugation for 10 min was used. [3-3H]Quinucli- 
dinyl benzilate (8.4 Ci/mmol) was from The Radio- 
chemical Centre, Amersham. Dexetimide was a 
generous gift of Janssen Pharmaceutics, Beerse, 
Belgium. a-Bungarotoxin (a-Btx) was purified from 
crude Bungarus multicintus venom [ 121. Other chemi- 
cals were of analytical grade. 
134 
Binding of [3H]QNB was assayed as follows: 
Aliquots of fly homogenate (containing up to 0.7 mg 
protein) were incubated at 25°C in 0.06 M NaCl, 
1 mg/ml BSA, 0.025 M Tris-HCl, pH 7.4 (Buffer I), 
in total vol. 0.25 ml. Reaction was started by addition 
of the appropriate concentration of [3H]QNB and 
was terminated by diluting with 2 ml buffer I follow- 
ed immediately by vacuum filtration through a glass- 
fiber filter (GF/C, Tamar, Israel). The filter was then 
washed 3 times with 2 ml portions of buffer I, dried 
and placed in vials containing 4 ml 33% (v/v) Triton 
X-100,0.8% 2,5-diphenyloxazole (PPO) and 0.01% 
1,4-bis[2-(5-phenyloxazolyl)] benzene (POPOP) in 
toluene. Vials were maintained for 12-24 h at 25°C 
and counted by liquid scintillation spectrometry. 
3. Results and discussion 
Under the conditions employed, binding of 
[3H]QNB was linearly proportional to the amount of 
head homogenate present. Specific binding, defined 
as total binding minus binding occurring in the pres- 
ence of 0.1 mM atropine, was saturable (fig. 1). After 
incubation for 1 h, maximum specific binding was 
obtained with [3H]QNB concentrations higher than 
5 nM. Non-specific binding at that concentration was 
<5% of total. Half-saturation occurs at about 2 nM. 
Concentration of binding sites in head homogenate 
was found to be 0.08 + 0.03 pmol/mg protein. 
The time dependence of binding is described in 
fig.2. Under the conditions employed, binding 
reached half-maximal values in about 5 min and maxi- 
mal values in about 40 min. The on-rate constant for 
the formation of [3H]QNB-receptor complex was 
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Fig. 1. [‘HI QNB binding to Drosophila head homogenate after 
incubation for 1 h at various [3H]QNB concentrations. 
Specific binding is defined as total binding minus binding in 
the presence of lo-’ M atropine. 
calculated to be KI 1.5 X 10’ M-’ . s-l, assuming a 
simple bimolecular reaction between ligand and 
receptor. 
Specificity of binding and pharmacological pro- 
perties were studied by testing the effect of various 
cholinergic ligands on binding. Concentrations of 
various drugs that displaced binding by 50% (EDso) 
are given in table 1. The muscarinic ligands dexeti- 
Table 1 
Effect of various cholinergic ligands on [‘HJQNB-binding 
to Drosophila head homogenate 
Ligand ED,, 
Dexetimide 
Scopolamine 
Atropine 
Acetylcholinea 
Pilocarpine 
D-Tubocurarine 
D,L-Muscarine 
Decamethoniumb 
Nicotineb 
4X 10-9M 
7 x 1O-9 M 
3 x lo-’ M 
3 X lo-’ M 
3 x lo-’ M 
4X IO-‘M 
6 X lo-’ M 
> 1O-3 M 
> lo-’ M 
aDetermined in the presence of 10-s M diethylfluorophos- 
phate, which completely inhibits acetylcholinesterase 
bTested up to a concentration of 10-a M 
Aliquots containing 0.7 mg head protein were preincubated 
for 25 min with the appropriate concentration of ligand, 
except for acetylcholine, which was preincubated for 15 min 
Reaction was started by addition of [‘H]QNB (5 nM) and 
was carried out for 60 min at 25°C. ED,, was determined 
from plots of relative [‘H]QNB binding versus ligand con- 
centration. 
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Fig.2. Time dependence of [ ‘H]QNB binding to Drosophila 
head homogenate. Incubation medium contained 5 nM 
[‘H]QNB and 0.7 mg head protein. 
mide, scopolamine and atropine were most powerful 
in protecting against [jH]QNB binding. D,L-Musca- 
rine, which has no effect on binding of a-Btx to fly 
nicotinic receptors at concentrations up to 1 mM 
[7], inhibits [3H]QNB binding withED5e 6 X lo-’ M. 
Acetylcholine is also effective in protecting [3H] QNB 
binding-sites (ED5e 3 X lo-’ M). Nicotine, which has 
high affinity for fly cholinergic nicotinic receptor [7] , 
is not effective in protecting [3H]QNB binding-sites 
at concentrations up to 1 mM. a-Btx had no signifi- 
cant effect on [3H]QNB binding at 10 PM. 
The above data clearly indicate that Drosophila 
contain a muscarinic cholinergic receptor, as revealed 
by [3H]QNB binding. Pharmacological properties of 
that receptor are similar to those reported for mamma- 
lian muscarinic receptor [lo] . However, whereas 
mammalian brain is an order of magnitude richer in 
muscarinic receptors than in nicotinic receptors 
[10,13], in Drosophila head concentration of the nico- 
tinic receptor PO.4 pmol/mg, [8] ) is higher than that 
of the muscarinic receptor. It should be noted that 
our assay reveals only binding to particulate musca- 
rinic receptors, and additional, soluble [jH]QNB- 
binding components cannot be excluded. 
The observation that mammals and insects, which 
are far remote on the phylogenetic scale, both con- 
tain distinct cholinergic muscarinic and nicotinic 
receptors, indicates that both types of cholinergic 
receptor specificities evolved early during evolution. 
It is possible that invertebrates contain additional 
135 
Volume 81, number 1 FEBS LETTERS September 1977 
types of cholinergic receptors. It has been reported, 
on the basis of electrophysiological and pharma- 
cological studies, that molluscan neurons contain 
three types of cholinergic receptors, two of which are 
nicotinic, the third displaying neither a classical nico- 
tinic nor a classical muscarinic nature [ 141 . Jewess et 
al. [ 151 reported that high-speed supernatafit of 
house-fly heads homogenate contains a cholinergic 
receptor with a mixed nicotinic and muscarinic nature, 
that has high affinity for muscarinic ligands, e.g., 
dexetimide and atropine, and for nicotinic ligands, 
e.g., nicotine and decamethonium. The preparation 
also binds QNB (cited as personal communication, 
[9] ). It is of interest to note that neither the nico- 
tinic receptor of Drosophila [7,9] nor the muscarinic 
receptor reported here, display high affinity for deca- 
methonium. The decamethonium binding component 
may therefore represent an additional type of choliner- 
gic receptor. Further biochemical studies, combined 
with genetic dissection methods for which Drosophila 
is particularly suitable [ 161 ; may shed light on the 
molecular and physiological characteristics of various 
cholinergic receptors in flies. One should also note 
that further characterization of cholinergic receptors 
in insects may lead to developing more effective insec- 
ticides [ 171 . 
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